Loading institutional data...
Loading institutional data...
No institutional (13F) filings cover this company, so the Overview and 13F tabs are thin. Everything drawn from its SEC filings is here.
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow on any basis, so a reverse DCF can't be run.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$5.3M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 3 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 0%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 3 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-16 · 15d old
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $29.2M 100.0% | $21.4M 100.0% | $26.3M 100.0% |
| Cost of Revenue | $26.6M 91.0% | $17.5M 81.5% | $22.0M 84.0% |
| Gross Profit | $2.6M 9.0% | $4.0M 18.5% | $4.2M 16.0% |
| Research & Development | $651K 2.2% | $559K 2.6% | $741K 2.8% |
| Selling, General & Admin | $1.4M 4.8% | $601K 2.8% | $571K 2.2% |
| Total Operating Expenses | $2.5M 8.6% | $1.8M 8.2% | $1.8M 6.9% |
| Operating Income | $104K 0.4% | $2.2M 10.3% | $2.4M 9.2% |
| Interest Expense | $159K 0.5% | $151K 0.7% | $70K 0.3% |
| Interest & Investment Income | $223 0.0% | $548 0.0% | $1K 0.0% |
| Pretax Income | $86K 0.3% | $2.1M 10.0% | $2.3M 8.7% |
| Income Tax Expense | $67K 0.2% | $269K 1.3% | $307K 1.2% |
| Net Income | $2K 0.0% | $1.8M 8.5% | $1.9M 7.3% |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~3.8% on $4.2M of debt.
Cash of $122K is below short-term debt of $2.0M — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-10-16
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 0% against ROIC 0% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cost of Revenue | 84.0 | 81.5 | 91.0 |
| Gross Profit | 16.0 | 18.5 | 9.0 |
| R&D | 2.8 | 2.6 | 2.2 |
| SG&A | 2.2 | 2.8 | 4.8 |
| Operating Income | 9.2 | 10.3 | 0.4 |
| Income Tax | 1.2 | 1.3 | 0.2 |
| Net Income | 7.3 | 8.5 | 0.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MAMK: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Ranked against 14 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CTAS | $86.6B | 44.4× | 28.4× | 7.7× | 8.9% | 50.7% | 17.8% | 38.9% | 26.4% | 0.7× | 446 |
| RL | $23.9B | 26.5× | 16.4× | 2.9× | 14.6% | 69.9% | 11.6% | 33.1% | 23.1% | -0.5× | 193 |
| LULU | $12.7B | 8.3× | 4.7× | 1.1× | 4.9% | 56.6% | 14.2% | 31.8% | 31.8% | 0.0× | 199 |
| LEVI | $8.7B | 15.6× | 10.1× | 1.4× | 4.1% | 61.7% | 9.2% | 25.4% | 17.4% | 0.3× | 57 |
| VFC | $7.2B | 28.6× | — | 0.8× | 1.1% | 54.8% | 2.7% | 13.8% | 4.7% | — | 145 |
| KTB | $4.1B | 18.7× | 13.6× | 1.3× | 20.9% | 45.2% | 7.2% | 40.3% | 13.3% | 2.8× | 91 |
| PVH | $4.1B | 169.8× | 11.3× | 0.5× | 3.4% | 57.5% | 0.3% | 0.5% | 0.4% | 3.2× | 82 |
| FIGS | $3.6B | 113.5× | 74.2× | 5.7× | 13.6% | 66.5% | 5.4% | 7.8% | 7.8% | -1.7× | 31 |
| COLM | $3.3B | 19.7× | 10.7× | 1.0× | 0.9% | 50.5% | 5.2% | 10.4% | 10.4% | -1.7× | 64 |
| GIII | $1.3B | 20.1× | 6.8× | 0.4× | -7.0% | 39.4% | 2.3% | 3.8% | 3.8% | -3.0× | 40 |
| CRI | $1.2B | 13.2× | 6.7× | 0.4× | 1.9% | 45.4% | 3.2% | 9.9% | 6.2% | 0.4× | 54 |
| OXM | $429M | — | 21.5× | 0.3× | -2.6% | 60.7% | -1.9% | -5.4% | -4.4% | 4.3× | 25 |
| JILL | $353M | 13.1× | — | 0.6× | -2.3% | 68.7% | 4.7% | 23.0% | 14.3% | — | 14 |
| MAMK | $216M | — | — | 7.4× | 36.3% | 9.0% | 0.0% | 0.0% | 0.0% | — | — |
| SGC | $201M | 27.4× | — | 0.4× | 0.1% | 37.6% | 1.2% | 3.6% | 2.4% | — | 21 |
Peers = companies sharing MAMK's sector (Miscellaneous Fabricated Textile Products) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Earns -11.2pts against its cost of capital — capital is being consumed, not created.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2023 | 30.3% | 11.6% (today's — no rate published for this year) | 18.7pts |
| FY2024 | 12.0% | 10.8% | 1.2pts |
| FY2025 | 0.4% | 10.7% | -10.3pts |
| Now | 0.0% | 11.6% | -11.6pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2023 | 16.0% | 9.2% | 7.3% |
| FY2024 | 18.5% | 10.3% | 8.5% |
| FY2025 | 9.0% | 0.4% | 0.0% |
Return on equity (0%) and return on invested capital (0%) are within a couple of points in FY2025, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
The spread has been narrowing over the last three years.
Free cash flow has fallen short of reported profit in 3 of the last three years.
Accruals are 24.21% of assets — profit is running ahead of cash, which is the earliest quality warning available.
Missing from our data, so excluded from this answer: share_based_compensation.
Stressed coverage falls to 0.5x — below the level at which interest is reliably covered.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 0.65x |
| 5% | 0.62x |
| 10% | 0.59x |
| 15% | 0.55x |
| 20% | 0.52x |
| 25% | 0.49x |
| 30% | 0.46x |
| 35% | 0.42x |
| 40% | 0.39x |
| 45% | 0.36x |
| 50% | 0.33x |
| 55% | 0.29x |
| 60% | 0.26x |
Balance sheet at 2025-10-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
Free cash flow is negative, so debt service depends on the cash balance rather than on the business.
No positive free cash flow to discount, so the price cannot be expressed as a growth requirement.
No material counter-signal in the checked set: reverse-DCF implied growth, historical FCF CAGR, per-year FCF growth distribution, reporting-basis breaks, discount rate used, free-cash-flow basis (stock comp charged?).
Missing from our data, so excluded from this answer: free_cash_flow.
| Step | Amount | Running total |
|---|---|---|
| Net income | $2,026 | $2,026 |
| Share-based comp | not reported | not reported |
| Other non-cash & working capital | −$5M | −$5M |
| Operating cash flow | −$5M | −$5M |
| Capex | −$56,877 | −$5M |
| Free cash flow | −$5M | −$5M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2024 | -18.4% | not reported | not reported |
| FY2025 | 36.3% | 59.6% | 23.3 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2023 | not reported | not reported | not reported | not reported |
| FY2024 | 105.4 days | 55 days | 44.5 days | 116 days |
| FY2025 | 123.4 days | 89.2 days | 44.5 days | 168.1 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2023 | not reported |
| FY2024 | 27.4 percent |
| FY2025 | 24.2 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.